Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (466)	12/24/2018 10:28:30 AM
From: ghmm	3 Recommendations Recommended By A.J. Mullen DaveAu rkrw Read Replies (1) \| Respond to of 684

Was doing quick looks at the list quite a lot with 2-3Q's (or less) of cash left of course they may cut some costs to stretch it but if the market doesn't settle soon don't know how they go on. What is amazing is doing quick looks seeing how many companies have the top 3-4 management salaries making up 15-20% of the market caps... they could stretch their runways by cutting there :).

To: rkrw who wrote (466)	12/24/2018 10:47:47 AM
From: bmaz001	8 Recommendations Recommended By A.J. Mullen Biotech Jim DonShimoda ghmm Lance Bredvold and 3 more members Read Replies (5) \| Respond to of 684

I've uploaded to Google Sheets some details about 100 cheap biotechs. This information is extracted from the most recent 10-Q filings as well as other sources. I don't make any attempts to modify/correct the data so be sure to double-check things that don't look right. To facilitate additional research, there are links to the latest 10-Q as well as Yahoo Finance in columns 'O' and 'P'. I believe that I have taken the necessary steps to share this spreadsheet with anyone who knows the link, so let me know if you can/can't access it. A few things worth noting are: My 'Lazy EV' column is a quick attempt at calculating Enterprise Value given the information that I've extracted. The records are sorted by ascending 'Lazy EV'. The 'Share Price' is as of 12/21 (Friday). The last five columns are meant to show the number of drugs in the company's pipeline. docs.google.com